BANEOCIN

This brand name is authorized in Austria, Estonia, Lithuania, Romania, Singapore.

Active ingredients

The drug BANEOCIN contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII 057Y626693 - NEOMYCIN SULFATE
 

Neomycin is an aminoglycoside antibiotic and acts by binding to polysomes, inhibiting protein synthesis and generating errors in the transcription of the genetic code.
 
Read more about Neomycin
2
UNII 89Y4M234ES - BACITRACIN ZINC
 
Read more about Bacitracin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
D06AX Other antibiotics for topical use D Dermatologicals → D06 Antibiotics and chemotherapeutics for dermatological use → D06A Antibiotics for topical use
Discover more medicines within D06AX

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1019483, 1019494, 1869981
LT Valstybinė vaistų kontrolės tarnyba 1010624, 1015317, 1078459, 1081605, 1085788, 1085790, 1086100, 1087703, 1087812, 1088349
PL Rejestru Produktów Leczniczych 100241841
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W41668001, W41668002, W41669001
SG Health Sciences Authority 00676P, 00678P

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈